Diabetes and Peripheral Arterial Disease in Men: Trends in Prevalence, Mortality, and Effect of Concomitant Coronary Disease

Overview

Journal Clin Cardiol

Specialty Cardiology & Vascular Diseases

Date 2009 Aug 18

PMID 19685517

Citations 5

Authors

Masoor Kamalesh

Jianzhao Shen

Affiliations

Soon will be listed here.

Abstract

Background: Recent data on trends in diabetes mellitus (DM) prevalence and long-term effect on mortality in peripheral arterial disease (PAD) subjects is lacking.

Methods: All subjects discharged from any VA medical center between October 1990 to September 1997 with an International Classification of Diseases (ICD)-9 code for PAD and DM in the discharge summary were retrospectively identified. Demographic data were extracted from the database. Mortality data were obtained from the Beneficiary Information and Resource Locator. Outcome measures were age specific DM prevalence over time, and short-term and long-term mortality.

Results: Of 33, 629 patients with PAD, 9474 (29%) had DM. Diabetes mellitus subjects were less likely to be white and had more comorbidities. Mean length of hospital stay was greater for DM (22.3 d vs 18.7 days, P < 0.001). Mortality was higher for DM at 180 days (9.8% vs 8.4%, P < 0.001), 1 year (16.4% vs 13.7%, P < 0.001), and continues to increase at 8 years of follow-up. Logistic regression analysis showed no interaction between DM and coronary artery disease (CAD).

Conclusions: Diabetes mellitus increases all-cause mortality in subjects with PAD starting at 6 months post-discharge and continues to be higher even at 8 years of follow-up. There was a lack of interaction of DM and CAD on mortality in this cohort of subjects with PAD.

Citing Articles

The Importance of Prediabetes Screening in the Prevention of Cardiovascular Disease.

Cosic V, Jakab J, Pravecek M, Miskic B Med Arch. 2023; 77(2):97-104.

PMID: 37260805 PMC: 10227840. DOI: 10.5455/medarh.2023.77.97-104.

Comparison of Longitudinal Skeletal Thigh Muscle Findings With Magnetic Resonance Imaging in Patients With Peripheral Artery Disease With-Versus-Without Diabetes Mellitus.

Gimnich O, Ortiz C, Yang E, Chen C, Virani S, Kougias P Am J Cardiol. 2022; 181:130-138.

PMID: 35999068 PMC: 11600339. DOI: 10.1016/j.amjcard.2022.06.060.

Insulin Treatment Forces Arteriogenesis in Diabetes Mellitus by Upregulation of the Early Growth Response-1 (Egr-1) Pathway in Mice.

Thulasingam S, Krishnasamy S, C D, Lasch M, Vedantham S, Deindl E Int J Mol Sci. 2019; 20(13).

PMID: 31284541 PMC: 6651530. DOI: 10.3390/ijms20133320.

Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.

Brannick B, Dagogo-Jack S Endocrinol Metab Clin North Am. 2018; 47(1):33-50.

PMID: 29407055 PMC: 5806140. DOI: 10.1016/j.ecl.2017.10.001.

Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study.

Golledge J, Quigley F, Velu R, Walker P, Moxon J Cardiovasc Diabetol. 2014; 13:147.

PMID: 25361884 PMC: 4230372. DOI: 10.1186/s12933-014-0147-2.

References

Wackers F, Young L, Inzucchi S, Chyun D, Davey J, Barrett E . Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004; 27(8):1954-61. DOI: 10.2337/diacare.27.8.1954. View

Kamalesh M, Feigenbaum H, Sawada S . Challenge of identifying patients with diabetes mellitus who are at low risk for coronary events by use of cardiac stress imaging. Am Heart J. 2004; 147(4):561-3. DOI: 10.1016/j.ahj.2003.12.012. View

Golomb B, Dang T, Criqui M . Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006; 114(7):688-99. DOI: 10.1161/CIRCULATIONAHA.105.593442. View

Rutter M, Nesto R . The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes. Nat Clin Pract Endocrinol Metab. 2006; 3(1):26-35. DOI: 10.1038/ncpendmet0352. View

Wright S, Petersen L, Lamkin R, Daley J . Increasing use of Medicare services by veterans with acute myocardial infarction. Med Care. 1999; 37(6):529-37. DOI: 10.1097/00005650-199906000-00002. View

Creager M, Jones D, Easton J, Halperin J, Hirsch A, Matsumoto A . Atherosclerotic Vascular Disease Conference: Writing Group V: medical decision making and therapy. Circulation. 2004; 109(21):2634-42. DOI: 10.1161/01.CIR.0000128522.98016.19. View

Beckman J, Jaff M, Creager M . The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit?. Circulation. 2006; 114(8):861-6. DOI: 10.1161/CIRCULATIONAHA.105.607846. View

Saw J, Bhatt D, Moliterno D, Brener S, Steinhubl S, Lincoff A . The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol. 2006; 48(8):1567-72. DOI: 10.1016/j.jacc.2006.03.067. View

. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003; 26(12):3333-41. DOI: 10.2337/diacare.26.12.3333. View

10.

Fisher S, Weber L, Goldberg J, Davis F . Mortality ascertainment in the veteran population: alternatives to the National Death Index. Am J Epidemiol. 1995; 141(3):242-50. DOI: 10.1093/oxfordjournals.aje.a117426. View

11.

Haffner S, Lehto S, Ronnemaa T, Pyorala K, Laakso M . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339(4):229-34. DOI: 10.1056/NEJM199807233390404. View

12.

Tierney W, McDonald C . Practice databases and their uses in clinical research. Stat Med. 1991; 10(4):541-57. DOI: 10.1002/sim.4780100406. View

13.

Pladevall M, Goff D, NICHAMAN M, Chan F, Ramsey D, Ortiz C . An assessment of the validity of ICD Code 410 to identify hospital admissions for myocardial infarction: The Corpus Christi Heart Project. Int J Epidemiol. 1996; 25(5):948-52. DOI: 10.1093/ije/25.5.948. View

14.

Kamalesh M, Feigenbaum H, Sawada S . Assessing prognosis in patients with diabetes mellitus--the Achilles' heel of cardiac stress imaging tests?. Am J Cardiol. 2007; 99(7):1016-9. DOI: 10.1016/j.amjcard.2006.10.071. View

15.

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

16.

Petersen L, Normand S, Daley J, McNeil B . Outcome of myocardial infarction in Veterans Health Administration patients as compared with medicare patients. N Engl J Med. 2001; 343(26):1934-41. DOI: 10.1056/NEJM200012283432606. View

17.

Fleming C, Fisher E, Chang C, Bubolz T, Malenka D . Studying outcomes and hospital utilization in the elderly. The advantages of a merged data base for Medicare and Veterans Affairs hospitals. Med Care. 1992; 30(5):377-91. DOI: 10.1097/00005650-199205000-00001. View

18.

Miller T, Redberg R, Wackers F . Screening asymptomatic diabetic patients for coronary artery disease: why not?. J Am Coll Cardiol. 2006; 48(4):761-4. DOI: 10.1016/j.jacc.2006.04.076. View

19.

Marso S, Hiatt W . Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006; 47(5):921-9. DOI: 10.1016/j.jacc.2005.09.065. View